{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:29:29Z","timestamp":1792783769726,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["427002014"],"award-info":[{"award-number":["427002014"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["427002014"],"award-info":[{"award-number":["427002014"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["427002014"],"award-info":[{"award-number":["427002014"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","award":["C.H.I.L.D.R.E.N. grant 2021"],"award-info":[{"award-number":["C.H.I.L.D.R.E.N. grant 2021"]}],"id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","award":["C.H.I.L.D.R.E.N. grant 2021"],"award-info":[{"award-number":["C.H.I.L.D.R.E.N. grant 2021"]}],"id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","award":["C.H.I.L.D.R.E.N. grant 2021"],"award-info":[{"award-number":["C.H.I.L.D.R.E.N. grant 2021"]}],"id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016469","name":"Takeda Pharmaceuticals International AG","doi-asserted-by":"crossref","award":["IISR-2021-200128"],"award-info":[{"award-number":["IISR-2021-200128"]}],"id":[{"id":"10.13039\/100016469","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016469","name":"Takeda Pharmaceuticals International AG","doi-asserted-by":"crossref","award":["IISR-2021-200128"],"award-info":[{"award-number":["IISR-2021-200128"]}],"id":[{"id":"10.13039\/100016469","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016469","name":"Takeda Pharmaceuticals International AG","doi-asserted-by":"crossref","award":["IISR-2021-200128"],"award-info":[{"award-number":["IISR-2021-200128"]}],"id":[{"id":"10.13039\/100016469","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016469","name":"Takeda Pharmaceuticals International AG","doi-asserted-by":"crossref","award":["IISR-2021-200128"],"award-info":[{"award-number":["IISR-2021-200128"]}],"id":[{"id":"10.13039\/100016469","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013710","name":"European Federation of Immunological Societies","doi-asserted-by":"publisher","award":["Fellowship"],"award-info":[{"award-number":["Fellowship"]}],"id":[{"id":"10.13039\/501100013710","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Academy of Allergy & Clinical Immunology","award":["Fellowship"],"award-info":[{"award-number":["Fellowship"]}],"id":[{"id":"https:\/\/ror.org\/03wa91e11","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Takeda","award":["honoraria"],"award-info":[{"award-number":["honoraria"]}],"id":[{"id":"https:\/\/ror.org\/04hjbmv12","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["FIS-PI21\/01642"],"award-info":[{"award-number":["FIS-PI21\/01642"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Patients with (X-linked) agammaglobulinemia (XLA) suffer from severe, recurrent infections potentially leading to life-threatening complications such as sepsis, meningoencephalitis and chronic lung disease. Early diagnosis and timely treatment can prevent infections and secondary complications, emphasizing a role for early detection of XLA via newborn screening (NBS). Our international multicenter survey study aimed to evaluate self-reported outcomes and parental perspectives in XLA patients to determine whether an early diagnosis is associated with better quality of life (QoL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>QoL-questionnaires included the PedsQL for children and SF-36, CVID_QOL, PADQOL-16 for adults. A new questionnaire was specifically developed for parents about an early diagnosis of XLA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 88 adult and 65 pediatric XLA patients, and 69 parents from 14 countries completed the survey. Patients with an early diagnosis reported less severe, recurrent infections and less hospitalization (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). QoL was significantly lower in multiple health domains for pediatric and adult patients with a late diagnosis compared to the general population. Patients with an early diagnosis reported similar QoL outcomes compared to the general population. Parents showed immense support for NBS for XLA stating that an early diagnosis prevents emotional insecurity, health damage, unnecessary diagnostics and allows early access to medical care and informed family planning.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study has shown supportive evidence to pursue an early diagnosis of XLA from both a self-reported clinical, health related QoL and parental perspective. The main plea from patients and parents is to achieve an early diagnosis for XLA and severe B-lymphocyte deficiencies with NBS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10875-025-01904-z","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T05:11:44Z","timestamp":1756098704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2993-7847","authenticated-orcid":false,"given":"Maartje","family":"Blom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelotte J.","family":"Duintjer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Jamee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"de Gier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark\u00e9ta","family":"Bloomfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Klocperk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlina","family":"Kralickova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan E.","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Boyarchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"\u010ci\u017en\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo\u0161","family":"Jese\u0148\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Sharapova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Skopovets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis I.","family":"Gonzalez-Granado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Palmeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Volpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Martin","family":"Nalda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia Rodriguez","family":"Tello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Soler-Palac\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Abolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pulvirenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Cinicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Wintergerst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godelieve J.","family":"de Bree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Merlijn","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L.","family":"Leavis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementien","family":"Vermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgil A.S.H.","family":"Dalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"van Aerde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Henriet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetty","family":"Jolink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Potjewijd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan","family":"Lankester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandoshi Rhea","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Berghuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Pac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.J.","family":"Shillitoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"1904_CR1","unstructured":"Lackey AE, Ahmad F. X-Linked Agammaglobulinemia. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025."},{"issue":"2","key":"1904_CR2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0092-8674(93)90667-F","volume":"72","author":"S Tsukada","year":"1993","unstructured":"Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 1993;72(2):279\u201390.","journal-title":"Cell"},{"issue":"6409","key":"1904_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/361226a0","volume":"361","author":"D Vetrie","year":"1993","unstructured":"Vetrie D, Vorechovsk\u00fd I, Sideras P, Holland J, Davies A, Flinter F, et al. The gene involved in X-linked agammaglobulinaemia is a member of the Src family of protein-tyrosine kinases. Nature. 1993;361(6409):226\u201333.","journal-title":"Nature"},{"issue":"1","key":"1904_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12016-021-08870-5","volume":"63","author":"M Cardenas-Morales","year":"2022","unstructured":"Cardenas-Morales M, Hernandez-Trujillo VP. Agammaglobulinemia: from X-linked to autosomal forms of disease. Clin Rev Allergy Immunol. 2022;63(1):22\u201335.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"1904_CR5","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1007\/s10875-022-01352-z","volume":"42","author":"A Bousfiha","year":"2022","unstructured":"Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42(7):1508\u201320.","journal-title":"J Clin Immunol"},{"issue":"2","key":"1904_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1385\/CRIAI:19:2:183","volume":"19","author":"ME Conley","year":"2000","unstructured":"Conley ME, Rohrer J, Minegishi Y. X-linked agammaglobulinemia. Clin Rev Allergy Immunol. 2000;19(2):183\u2013204.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9","key":"1904_CR7","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1073\/pnas.1817341116","volume":"116","author":"S Morosky","year":"2019","unstructured":"Morosky S, Wells AI, Lemon K, Evans AS, Schamus S, Bakkenist CJ, et al. The neonatal Fc receptor is a pan-echovirus receptor. Proc Natl Acad Sci U S A. 2019;116(9):3758\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1904_CR8","first-page":"935","volume":"27","author":"V Moschese","year":"2013","unstructured":"Moschese V, Martire B, Soresina A, Chini L, Graziani S, Monteferrario E, et al. Anti-infective prophylaxis for primary immunodeficiencies: what is done in Italian primary immunodeficiency network centers (IPINet) and review of the literature. J Biol Regul Homeost Agents. 2013;27(4):935\u201346.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"6","key":"1904_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/ACI.0000000000000584","volume":"19","author":"BMJ Shillitoe","year":"2019","unstructured":"Shillitoe BMJ, Gennery AR. An update on X-Linked agammaglobulinaemia: clinical manifestations and management. Curr Opin Allergy Clin Immunol. 2019;19(6):571\u20137.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"1904_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.aller.2013.09.013","volume":"43","author":"H Abolhassani","year":"2015","unstructured":"Abolhassani H, Hirbod-Mobarakeh A, Shahinpour S, Panahi M, Mohammadinejad P, Mirminachi B, et al. Mortality and morbidity in patients with X-linked agammaglobulinaemia. Allergol Immunopathol (Madr). 2015;43(1):62\u20136.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"2","key":"1904_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jaci.2020.03.001","volume":"146","author":"V Lougaris","year":"2020","unstructured":"Lougaris V, Soresina A, Baronio M, Montin D, Martino S, Signa S, et al. Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality. J Allergy Clin Immunol. 2020;146(2):429\u201337.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1904_CR12","doi-asserted-by":"publisher","first-page":"100018","DOI":"10.1016\/j.waojou.2019.100018","volume":"12","author":"ZA El-Sayed","year":"2019","unstructured":"El-Sayed ZA, Abramova I, Aldave JC, Al-Herz W, Bezrodnik L, Boukari R, et al. X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the world. World Allergy Organ J. 2019;12(3):100018.","journal-title":"World Allergy Organ J"},{"issue":"4","key":"1904_CR13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s10875-014-0003-x","volume":"34","author":"J Routes","year":"2014","unstructured":"Routes J, Abinun M, Al-Herz W, Bustamante J, Condino-Neto A, De La Morena MT, et al. ICON: the early diagnosis of congenital immunodeficiencies. J Clin Immunol. 2014;34(4):398\u2013424.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1904_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3349\/ymj.2008.49.1.28","volume":"49","author":"JK Chun","year":"2008","unstructured":"Chun JK, Lee TJ, Song JW, Linton JA, Kim DS. Analysis of clinical presentations of Bruton disease: a review of 20 years of accumulated data from pediatric patients at severance hospital. Yonsei Med J. 2008;49(1):28\u201336.","journal-title":"Yonsei Med J"},{"issue":"4","key":"1904_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10875-022-01237-1","volume":"42","author":"D O\u2019Toole","year":"2022","unstructured":"O\u2019Toole D, Groth D, Wright H, Bonilla FA, Fuleihan RL, Cunningham-Rundles C, et al. X-Linked agammaglobulinemia: infection frequency and infection-Related mortality in the USIDNET registry. J Clin Immunol. 2022;42(4):827\u201336.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1904_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1006\/clim.2002.5241","volume":"104","author":"A Plebani","year":"2002","unstructured":"Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, Cardinale F, et al. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin Immunol. 2002;104(3):221\u201330.","journal-title":"Clin Immunol"},{"issue":"4","key":"1904_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","volume":"85","author":"JA Winkelstein","year":"2006","unstructured":"Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-Linked agammaglobulinemia: report on a united States registry of 201 patients. Medicine. 2006;85(4):193\u2013202.","journal-title":"Medicine"},{"issue":"6","key":"1904_CR18","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1007\/s10875-023-01502-x","volume":"43","author":"V Hernandez-Trujillo","year":"2023","unstructured":"Hernandez-Trujillo V, Zhou C, Scalchunes C, Ochs HD, Sullivan KE, Cunningham-Rundles C, et al. A registry study of 240 patients with X-Linked agammaglobulinemia living in the USA. J Clin Immunol. 2023;43(6):1468\u201377.","journal-title":"J Clin Immunol"},{"issue":"8","key":"1904_CR19","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s10875-023-01551-2","volume":"43","author":"A Nishimura","year":"2023","unstructured":"Nishimura A, Uppuluri R, Raj R, Swaminathan VV, Cheng Y, Abu-Arja RF, et al. An international survey of allogeneic hematopoietic cell transplantation for X-Linked agammaglobulinemia. J Clin Immunol. 2023;43(8):1827\u201339.","journal-title":"J Clin Immunol"},{"issue":"13","key":"1904_CR20","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1182\/blood.2021014687","volume":"139","author":"MH Albert","year":"2022","unstructured":"Albert MH, Slatter MA, Gennery AR, G\u00fcng\u00f6r T, Bakunina K, Markovitch B, et al. Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT inborn errors working party analysis. Blood. 2022;139(13):2066\u201379.","journal-title":"Blood"},{"issue":"5","key":"1904_CR21","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.jaci.2021.10.017","volume":"149","author":"AC Lankester","year":"2022","unstructured":"Lankester AC, Neven B, Mahlaoui N, von Asmuth EGJ, Courteille V, Alligon M, et al. Hematopoietic cell transplantation in severe combined immunodeficiency: the SCETIDE 2006\u20132014 European cohort. J Allergy Clin Immunol. 2022;149(5):1744\u2013e548.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"1904_CR22","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1182\/blood.2020005590","volume":"136","author":"R Chiesa","year":"2020","unstructured":"Chiesa R, Wang J, Blok HJ, Hazelaar S, Neven B, Moshous D, et al. Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults. Blood. 2020;136(10):1201\u201311.","journal-title":"Blood"},{"issue":"5","key":"1904_CR23","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s10875-016-0284-3","volume":"36","author":"BA Bryan","year":"2016","unstructured":"Bryan BA, Battersby A, Shillitoe BM, Barge D, Bourne H, Flood T, et al. Respiratory health and related quality of life in patients with congenital agammaglobulinemia in the Northern region of the UK. J Clin Immunol. 2016;36(5):472\u20139.","journal-title":"J Clin Immunol"},{"issue":"4","key":"1904_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10875-022-01222-8","volume":"42","author":"K Altman","year":"2022","unstructured":"Altman K, Zhou C, Hernandez-Trujillo V, Scalchunes C, Rawlings DJ, de la Morena MT. Health-Related quality of life in 91 patients with X-Linked agammaglobulinemia. J Clin Immunol. 2022;42(4):811\u20138.","journal-title":"J Clin Immunol"},{"issue":"5","key":"1904_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/MD.0b013e318187ed81","volume":"87","author":"JA Winkelstein","year":"2008","unstructured":"Winkelstein JA, Conley ME, James C, Howard V, Boyle J. Adults with X-linked agammaglobulinemia: impact of disease on daily lives, quality of life, educational and socioeconomic status, knowledge of inheritance, and reproductive attitudes. Med (Baltim). 2008;87(5):253\u20138.","journal-title":"Med (Baltim)"},{"issue":"2\u20133","key":"1904_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.clim.2005.11.002","volume":"118","author":"V Howard","year":"2006","unstructured":"Howard V, Greene JM, Pahwa S, Winkelstein JA, Boyle JM, Kocak M, et al. The health status and quality of life of adults with X-linked agammaglobulinemia. Clin Immunol. 2006;118(2\u20133):201\u20138.","journal-title":"Clin Immunol"},{"issue":"11","key":"1904_CR27","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1182\/blood-2011-08-371021","volume":"119","author":"S Borte","year":"2012","unstructured":"Borte S, von D\u00f6beln U, Fasth A, Wang N, Janzi M, Winiarski J, et al. Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood. 2012;119(11):2552\u20135.","journal-title":"Blood"},{"key":"1904_CR28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fimmu.2011.00012","volume":"2","author":"MC van Zelm","year":"2011","unstructured":"van Zelm MC, van der Burg M, Langerak AW, van Dongen JJ. PID comes full circle: applications of V(D)J recombination excision circles in research, diagnostics and newborn screening of primary immunodeficiency disorders. Front Immunol. 2011;2:12.","journal-title":"Front Immunol"},{"key":"1904_CR29","doi-asserted-by":"publisher","unstructured":"Kelleher KJ, Gardner W, Kemper AR, Chavez L, Pajer K, Rosic T. Principles for primary care screening in the context of population health. Acad Pediatr. 2024.\u00a0https:\/\/doi.org\/10.1016\/j.acap.2024.02.015.","DOI":"10.1016\/j.acap.2024.02.015"},{"issue":"8","key":"1904_CR30","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","volume":"39","author":"JW Varni","year":"2001","unstructured":"Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39(8):800\u201312.","journal-title":"Med Care"},{"issue":"6","key":"1904_CR31","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jaip.2016.07.012","volume":"4","author":"I Quinti","year":"2016","unstructured":"Quinti I, Pulvirenti F, Giannantoni P, Hajjar J, Canter DL, Milito C, et al. Development and initial validation of a questionnaire to measure Health-Related quality of life of adults with common variable immune deficiency: the cvid_qol questionnaire. J Allergy Clin Immunol Pract. 2016;4(6):1169\u2013e794.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"1904_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41687-019-0101-x","volume":"3","author":"JB Andersen","year":"2019","unstructured":"Andersen JB, Midttun K, Feragen KJB. Measuring quality of life of primary antibody deficiency patients using a disease-specific health-related quality of life questionnaire for common variable immunodeficiency (CVID_QoL). J Patient Rep Outcomes. 2019;3(1):15.","journal-title":"J Patient Rep Outcomes"},{"key":"1904_CR33","doi-asserted-by":"crossref","unstructured":"Ballow M, Conaway MR, Sriaroon P, Rachid RA, Seeborg FO, Duff CM et al. Construction and validation of a novel disease-specific quality-of-life instrument for patients with primary antibody deficiency disease (PADQOL-16). J Allergy Clin Immunol. 2017;139(6):2007-10.e8.","DOI":"10.1016\/j.jaci.2016.11.029"},{"issue":"6","key":"1904_CR34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"issue":"1","key":"1904_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/1744666X.2018.1413349","volume":"14","author":"E Carrillo-Tapia","year":"2018","unstructured":"Carrillo-Tapia E, Garc\u00eda-Garc\u00eda E, Herrera-Gonz\u00e1lez NE, Yamazaki-Nakashimada MA, Staines-Boone AT, Segura-Mendez NH, et al. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains. Expert Rev Clin Immunol. 2018;14(1):83\u201393.","journal-title":"Expert Rev Clin Immunol"},{"issue":"32","key":"1904_CR36","doi-asserted-by":"publisher","first-page":"e4544","DOI":"10.1097\/MD.0000000000004544","volume":"95","author":"XF Chen","year":"2016","unstructured":"Chen XF, Wang WF, Zhang YD, Zhao W, Wu J, Chen TX. Clinical characteristics and genetic profiles of 174 patients with X-linked agammaglobulinemia: report from shanghai, China (2000\u20132015). Med (Baltim). 2016;95(32):e4544.","journal-title":"Med (Baltim)"},{"key":"1904_CR37","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.3389\/fimmu.2019.02987","volume":"10","author":"ZA El-Sayed","year":"2019","unstructured":"El-Sayed ZA, Radwan N. Newborn screening for primary immunodeficiencies: the gaps, challenges, and outlook for developing countries. Front Immunol. 2019;10:2987.","journal-title":"Front Immunol"},{"issue":"7","key":"1904_CR38","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s10875-014-0072-x","volume":"34","author":"P Titman","year":"2014","unstructured":"Titman P, Allwood Z, Gilmour C, Malcolmson C, Duran-Persson C, Cale C, et al. Quality of life in children with primary antibody deficiency. J Clin Immunol. 2014;34(7):844\u201352.","journal-title":"J Clin Immunol"},{"issue":"4","key":"1904_CR39","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10875-008-9270-8","volume":"29","author":"A Soresina","year":"2009","unstructured":"Soresina A, Nacinovich R, Bomba M, Cassani M, Molinaro A, Sciotto A, et al. The quality of life of children and adolescents with X-linked agammaglobulinemia. J Clin Immunol. 2009;29(4):501\u20137.","journal-title":"J Clin Immunol"},{"issue":"5","key":"1904_CR40","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1111\/apa.15752","volume":"110","author":"AK Berg","year":"2021","unstructured":"Berg AK, Diseth TH, Abrahamsen TG, Halvorsen K, Reinfjell T, Erichsen HC. Primary antibody deficiency: the impact on the quality of life and mental health of affected children and their parents. Acta Paediatr. 2021;110(5):1645\u201352.","journal-title":"Acta Paediatr"},{"key":"1904_CR41","doi-asserted-by":"publisher","first-page":"108931","DOI":"10.1016\/j.clim.2022.108931","volume":"236","author":"JT Anderson","year":"2022","unstructured":"Anderson JT, Cowan J, Condino-Neto A, Levy D, Prusty S. Health-related quality of life in primary immunodeficiencies: impact of delayed diagnosis and treatment burden. Clin Immunol. 2022;236:108931.","journal-title":"Clin Immunol"},{"key":"1904_CR42","doi-asserted-by":"publisher","unstructured":"Jones GL, Vogt KS, Chambers D, Clowes M, Shrimpton A. What is the burden of Immunoglobulin replacement therapy in adult patients with primary immunodeficiencies?? A systematic review. Front Immunol. 2018;9.\u00a0https:\/\/doi.org\/10.3389\/fimmu.2018.01308.","DOI":"10.3389\/fimmu.2018.01308"},{"issue":"1","key":"1904_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12016-022-08949-7","volume":"65","author":"S Chawla","year":"2023","unstructured":"Chawla S, Jindal AK, Arora K, Tyagi R, Dhaliwal M, Rawat A. T cell abnormalities in X-Linked agammaglobulinaemia: an updated review. Clin Rev Allergy Immunol. 2023;65(1):31\u201342.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"1904_CR44","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2174\/156652307781369128","volume":"7","author":"T Moreau","year":"2007","unstructured":"Moreau T, Calmels B, Barlogis V, Michel G, Tonnelle C, Chabannon C. Potential application of gene therapy to X-linked agammaglobulinemia. Curr Gene Ther. 2007;7(4):284\u201394.","journal-title":"Curr Gene Ther"},{"issue":"6","key":"1904_CR45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/ACI.0000000000000952","volume":"23","author":"LM Ott de Bruin","year":"2023","unstructured":"Ott de Bruin LM, Lankester AC, Staal FJT. Advances in gene therapy for inborn errors of immunity. Curr Opin Allergy Clin Immunol. 2023;23(6):467\u201377.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"1904_CR46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11882-014-0510-0","volume":"15","author":"B Bestas","year":"2015","unstructured":"Bestas B, Turunen JJ, Blomberg KEM, Wang Q, M\u00e5nsson R, El Andaloussi S, et al. Splice-Correction strategies for treatment of X-Linked agammaglobulinemia. Curr Allergy Asthma Rep. 2015;15(3):4.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"2","key":"1904_CR47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/crispr.2020.0080","volume":"4","author":"DH Gray","year":"2021","unstructured":"Gray DH, Villegas I, Long J, Santos J, Keir A, Abele A, et al. Optimizing integration and expression of Transgenic bruton\u2019s tyrosine kinase for CRISPR-Cas9-Mediated gene editing of X-Linked agammaglobulinemia. Crispr J. 2021;4(2):191\u2013206.","journal-title":"Crispr J"},{"key":"1904_CR48","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.omtm.2021.01.007","volume":"20","author":"BJ Seymour","year":"2021","unstructured":"Seymour BJ, Singh S, Certo HM, Sommer K, Sather BD, Khim S, et al. Effective, safe, and sustained correction of murine XLA using a UCOE-BTK promoter-based lentiviral vector. Mol Ther Methods Clin Dev. 2021;20:635\u201351.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"1904_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10875-020-00886-4","volume":"41","author":"M Blom","year":"2021","unstructured":"Blom M, Bredius RGM, Jansen ME, Weijman G, Kemper EA, Vermont CL, et al. Parents\u2019 perspectives and societal acceptance of implementation of newborn screening for SCID in the Netherlands. J Clin Immunol. 2021;41(1):99\u2013108.","journal-title":"J Clin Immunol"},{"issue":"Suppl 1Suppl 1","key":"1904_CR50","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1542\/peds.2015-3731H","volume":"137","author":"G Joseph","year":"2016","unstructured":"Joseph G, Chen F, Harris-Wai J, Puck JM, Young C, Koenig BA. Parental views on expanded newborn screening using Whole-Genome sequencing. Pediatrics. 2016;137(Suppl 1Suppl 1):S36\u201346.","journal-title":"Pediatrics"},{"key":"1904_CR51","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.pedn.2017.10.002","volume":"38","author":"JM DeLuca","year":"2018","unstructured":"DeLuca JM. Public attitudes toward expanded newborn screening. J Pediatr Nurs. 2018;38:e19\u201323.","journal-title":"J Pediatr Nurs"},{"issue":"1","key":"1904_CR52","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12955-020-01508-8","volume":"18","author":"F Albuquerque de Almeida","year":"2020","unstructured":"Albuquerque de Almeida F, Al MJ, Koymans R, Riistama J, Pauws S, Severens JL. Impact of hospitalisation on health-related quality of life in patients with chronic heart failure. Health Qual Life Outcomes. 2020;18(1):262.","journal-title":"Health Qual Life Outcomes"}],"updated-by":[{"DOI":"10.1007\/s10875-025-01944-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000}}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01904-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-025-01904-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01904-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:02:30Z","timestamp":1777309350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-025-01904-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1904"],"URL":"https:\/\/doi.org\/10.1007\/s10875-025-01904-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The online version of the article has been updated. Pere Soler-Palac\u00edn's name was corrected to \"Soler-Palac\u00edn P.\" instead of \"Palacin P.S\".","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10875-025-01944-5","URL":"https:\/\/doi.org\/10.1007\/s10875-025-01944-5","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This is a questionnaire study, participation was voluntary and returning the completed questionnaire implied consent. All data was analyzed anonymously. The study was approved by the Medical Ethics Committee of Leiden-Den Haag-Delft (LDD) (reference: N22.018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}],"article-number":"125"}}